MetaCap

Bruker Corporation (BRKR)

NASDAQ: BRKRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

56.46-5.64 (-9.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BRKR stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$1.10
Dividend yield
0.09% ($0.05)
Ex-dividend date
Dec 21, 2026
52-week range
32.37 – 68.98
Day range
56.13 – 61.10
Volume / Avg
2.25M / 2.32M
Beta
—

52-week range

$32.37$68.98

BRKR stock today

On Nov 20, BRKR ended the session at $56.46, shedding $5.64 (9.08%), versus the S&P 500's 3.70% decline. Shares are 18.2% below their 52-week high of $68.98, set on Nov 4, 2026 and 74.4% above the 52-week low of $32.37, in the middle of the past year's range. BRKR is up 19.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 19.4%.

Bruker has posted a net loss over the last twelve months (EPS of -$1.10), so its P/E ratio is not meaningful. Bruker pays an annual dividend of $0.05 per share, a 0.09% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Bruker

Company profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions.

Industry
Biotechnology: Laboratory Analytical Instruments
CEO
Dr. Frank H. Laukien Ph.D.
Headquarters
Billerica, MA
Employees
11,085
Website
bruker.com

Financial highlights

Full financials

In fiscal 2025, Bruker generated $3.44 billion in revenue, up 2.1% from fiscal 2024, its 5th consecutive year of revenue growth. Bruker reported a net loss of $8.6 million, compared with net income of $113.1 million a year earlier. Gross margin was 45.9% (down from 49.0%) and operating margin 2.0%.

Bruker annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$3.44B$3.37B$2.96B$2.53B$2.42B
Growth+2.08%+13.56%+17.14%+4.67%+21.66%
Net income$-8.60M$113.10M$427.20M$296.60M$277.10M
EPS (diluted)$-0.15$0.76$2.90$1.99$1.81

Analyst forecast

Forecast

Consensus (13 analysts)

buy

Avg. price target

$68.00+20.44%

  • Strong buy 1
  • Buy 5
  • Hold 6
  • Sell 1
  • Strong sell 0

Target range

Low $55.00High $85.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$0.45 vs $0.42
Surprise
+7.14%

Dividends

Dividend history
Annual dividend
$0.05
Last payment
$0.05
Ex-dividend date
Dec 21, 2026
Pay date
Jan 7, 2027

BRKR news

All BRKR news

Bruker peers

Industrials sector
BRKR peer companies
CompanyPrice% ChgMarket capCompare
BIOBio-Rad Laboratories Inc. Class A358.90-2.34%$9.65Bvs BRKR
AVTRAvantor Inc.14.84-1.85%$10.06Bvs BRKR
TXG10x Genomics Inc. Class A51.80-9.72%$6.81Bvs BRKR
ALMRAlamar Biosciences Inc.26.48-7.67%$1.84Bvs BRKR
RVTYRevvity Inc.145.22-4.20%$16.21Bvs BRKR
CTKBCytek Biosciences Inc.6.12-3.16%$800.40Mvs BRKR
PACBPacific Biosciences of California Inc.1.63-7.39%$508.95Mvs BRKR
NAUTNautilus Biotechnology Inc.2.12-2.30%$270.03Mvs BRKR

Indexes, lists and sector

Bruker stock FAQ

What is Bruker's stock price today?

BRKR last traded at $56.46 as of Nov 20, 4:00 PM EST, down 9.08% on the day. Prices are delayed at least 15 minutes.

Does Bruker pay a dividend?

Yes. Bruker pays $0.05 per share annually, a 0.09% yield. The most recent dividend of $0.05 had an ex-dividend date of Dec 21, 2026.

Who is Bruker's CEO?

Dr. Frank H. Laukien Ph.D. is the chief executive officer of Bruker Corporation, which has about 11,085 employees.

What is the BRKR 52-week high?

The 52-week high for BRKR is $68.98 and the 52-week low is $32.37. The stock is currently 18.2% below its high.

Compare BRKR